188 related articles for article (PubMed ID: 3313243)
1. Haemophilus influenzae type b: the search for a vaccine.
Robbins JB; Schneerson R
Pediatr Infect Dis J; 1987 Aug; 6(8):791-4. PubMed ID: 3313243
[TBL] [Abstract][Full Text] [Related]
2. National Advisory Committee on Immunization (NACI). Statement on Haemophilus influenzae type B conjugate vaccines for use in infants and children.
Can Commun Dis Rep; 1992 Dec; 18(23):169-76. PubMed ID: 1291012
[TBL] [Abstract][Full Text] [Related]
3. Capsular polysaccharide of Haemophilus influenzae type b as a vaccine.
Parke JC
Pediatr Infect Dis J; 1987 Aug; 6(8):795-8. PubMed ID: 3313244
[TBL] [Abstract][Full Text] [Related]
4. World-wide strategies for immunization against invasive Haemophilus influenzae type b disease.
Iwarson S
Vaccine; 1993; 11 Suppl 1():S28-9. PubMed ID: 8447169
[TBL] [Abstract][Full Text] [Related]
5. Conjugated Haemophilus influenzae type b vaccine.
Med Lett Drugs Ther; 1988 Apr; 30(764):47-8. PubMed ID: 3258400
[No Abstract] [Full Text] [Related]
6. Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates.
Chu C; Schneerson R; Robbins JB; Rastogi SC
Infect Immun; 1983 Apr; 40(1):245-56. PubMed ID: 6601061
[TBL] [Abstract][Full Text] [Related]
7. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.
Granoff DM; Rathore MH; Holmes SJ; Granoff PD; Lucas AH
Vaccine; 1993; 11 Suppl 1():S46-51. PubMed ID: 8447176
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children.
Claesson BA; Trollfors B; Lagergard T; Taranger J; Bryla D; Otterman G; Cramton T; Yang Y; Reimer CB; Robbins JB
J Pediatr; 1988 May; 112(5):695-702. PubMed ID: 3361379
[TBL] [Abstract][Full Text] [Related]
9. [Haemophilus vaccines. Their importance in tropical pediatrics].
Bégué P
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):912-6. PubMed ID: 1819437
[TBL] [Abstract][Full Text] [Related]
10. Effect of transplacentally acquired tetanus antibodies on the antibody responses to Haemophilus influenzae type b-tetanus toxoid conjugate and tetanus toxoid vaccines in Filipino infants.
Nohynek H; Gustafsson L; Capeding MR; Käyhty H; Olander RM; Pascualk L; Ruutu P
Pediatr Infect Dis J; 1999 Jan; 18(1):25-30. PubMed ID: 9951976
[TBL] [Abstract][Full Text] [Related]
11. Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial.
Gessner BD; Sutanto A; Linehan M; Djelantik IG; Fletcher T; Gerudug IK; Ingerani ; Mercer D; Moniaga V; Moulton LH; Moulton LH; Mulholland K; Nelson C; Soemohardjo S; Steinhoff M; Widjaya A; Stoeckel P; Maynard J; Arjoso S
Lancet; 2005 Jan 1-7; 365(9453):43-52. PubMed ID: 15643700
[TBL] [Abstract][Full Text] [Related]
12. Impact of haemophilus influenzae type b conjugate vaccine in South Africa and Argentina.
Martin M; Casellas JM; Madhi SA; Urquhart TJ; Delport SD; Ferrero F; Chamany S; Dayan GH; Rose CE; Levine OS; Klugman KP; Feikin DR
Pediatr Infect Dis J; 2004 Sep; 23(9):842-7. PubMed ID: 15361724
[TBL] [Abstract][Full Text] [Related]
13. Prevention of Haemophilus influenzae type b infections in Apache and Navajo children.
Santosham M; Rivin B; Wolff M; Reid R; Newcomer W; Letson GW; Almeido-Hill J; Thompson C; Siber GR
J Infect Dis; 1992 Jun; 165 Suppl 1():S144-51. PubMed ID: 1588150
[TBL] [Abstract][Full Text] [Related]
14. Prevention of Haemophilus influenzae type b disease: vaccines and passive prophylaxis.
Wenger JD; Ward JI; Broome CV
Curr Clin Top Infect Dis; 1989; 10():306-39. PubMed ID: 2679698
[No Abstract] [Full Text] [Related]
15. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants.
Mulholland K; Hilton S; Adegbola R; Usen S; Oparaugo A; Omosigho C; Weber M; Palmer A; Schneider G; Jobe K; Lahai G; Jaffar S; Secka O; Lin K; Ethevenaux C; Greenwood B
Lancet; 1997 Apr; 349(9060):1191-7. PubMed ID: 9130939
[TBL] [Abstract][Full Text] [Related]
16. Haemophilus influenzae type b polysaccharide vaccine.
Cates KL
Pediatr Ann; 1986 Jun; 15(6):461-3, 467-8. PubMed ID: 3523406
[No Abstract] [Full Text] [Related]
17. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine.
Eskola J; Olander RM; Hovi T; Litmanen L; Peltola S; Käyhty H
Lancet; 1996 Dec 21-28; 348(9043):1688-92. PubMed ID: 8973430
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group.
Holmes SJ; Lucas AH; Osterholm MT; Froeschle JE; Granoff DM
JAMA; 1991 Oct; 266(14):1960-5. PubMed ID: 1895474
[TBL] [Abstract][Full Text] [Related]
19. Development of a guinea pig model to assess immunogenicity of Haemophilus influenzae type b capsular polysaccharide conjugate vaccines.
Siber GR; Anderson R; Habafy M; Gupta RK
Vaccine; 1995 Apr; 13(6):525-31. PubMed ID: 7483772
[TBL] [Abstract][Full Text] [Related]
20. Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile.
Levine OS; Ortiz E; Contreras R; Lagos R; Vial P; Misraji A; Ferreccio C; Espinoza C; Adlerstein L; Herrera P
Am J Epidemiol; 1993 Jun; 137(11):1221-8. PubMed ID: 8322763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]